| August 2020 |
| 07 August |
Webinar on "Compassionate Capitalism" with Kiran Mazumdar-Shaw |
 |
| July 2020 |
| 25 July |
Biocon Bets Big on Biosimilars, Generics Unit for Fast Growth |
|
| 25 July |
Itolizumab to be a great opportunity for Biocon |
|
| 14 July |
Initial response to Covid drug Itolizumab 'extremely encouraging', says Biocon |
|
| 14 July |
Biocon eyes global markets to supply drug |
|
| 14 July |
Itolizumab best used pre-ventilator: Data |
|
| 14 July |
Mint Lite |
|
| June 2020 |
| 16 June |
Biosimilar Drugs can Help us Reach $1b Target Soon |
|
| 06 June |
Kiran Mazumdar-Shaw named EY World Entrepreneur of 2020 |
|
| May 2020 |
| 19 May |
Covid provides larger opportunity to shape the biosimilar landscape |
|
| 16 May |
Will invest Rs2,000 crore in small molecules in 3-4 years |
|
| March 2020 |
| 12 Mar |
Biocon wins patent case against Sanofi |
|
| 10 Mar |
Biocon's cancer biosimilar gets US FDA acceptance for review |
|
| February 2020 |
| 22 Feb |
Biocon chief is EY entrepreneur for 2019 |
|
| January 2020 |
| 27 Jan |
Biocon Biologics Eyes $200M. Plans IPO in 2 Yrs: Mazumdar-Shaw |
|
| 24 Jan |
Biocon Q3 PBT up 9% |
|
| 08 Jan |
Biocon optimistic about hitting $1 billion in revenue by FY22 on back of new launches |
|
